Zobrazeno 1 - 10
of 79
pro vyhledávání: '"Eric W Hall"'
Autor:
Heather Bradley, Eric W. Hall, Elizabeth M. Rosenthal, Patrick S. Sullivan, A. Blythe Ryerson, Eli S. Rosenberg
Publikováno v:
Hepatology Communications, Vol 4, Iss 3, Pp 355-370 (2020)
Hepatitis C virus (HCV) infection is a leading cause of liver‐related morbidity and mortality, and more than 2 million adults in the United States are estimated to be currently infected. Reducing HCV burden will require an understanding of demograp
Externí odkaz:
https://doaj.org/article/6eb5e4cc491f42ae818b00311fe88e49
Publikováno v:
BMC Infectious Diseases, Vol 18, Iss 1, Pp 1-14 (2018)
Abstract Background Hepatitis C virus (HCV) is the most common blood-borne viral infection in the United States. Previously, we used data from the National Health and Nutrition Examination Survey (NHANES) and mortality data from the National Vital St
Externí odkaz:
https://doaj.org/article/8cc27340404640eeb1596a878460d43d
Publikováno v:
Journal of Viral Hepatitis. 29:1115-1126
Adults at increased risk for hepatitis B virus (HBV) infection are recommended to receive vaccination. We conducted a cost utility analysis to evaluate approaches for implementing that recommendation in selected high-risk settings: community outreach
Autor:
Mark K. Weng, Mona Doshani, Mohammed A. Khan, Sharon Frey, Kevin Ault, Kelly L. Moore, Eric W. Hall, Rebecca L. Morgan, Doug Campos-Outcalt, Carolyn Wester, Noele P. Nelson
Publikováno v:
American Journal of Transplantation. 22:1714-1720
Autor:
Eric W Hall, Mark K Weng, Aaron M Harris, Sarah Schillie, Noele P Nelson, Ismael R Ortega-Sanchez, Elizabeth Rosenthal, Patrick S Sullivan, Ben Lopman, Jeb Jones, Heather Bradley, Eli S Rosenberg
Publikováno v:
The Journal of Infectious Diseases. 226:1041-1051
Background Although effective against hepatitis B virus (HBV) infection, hepatitis B (HepB) vaccination is only recommended for infants, children, and adults at higher risk. We conducted an economic evaluation of universal HepB vaccination among US a
Autor:
Kayoko Shioda, Heather Bradley, Travis Sanchez, Nicole Luisi, Patrick S. Sullivan, Mansour Fahimi, Eric W. Hall, Cherie Drenzek, Allison T. Chamberlain, Kathleen E. Toomey, Benjamin A. Lopman, Aaron J Siegler
Publikováno v:
The Journal of Infectious Diseases
Background Reported coronavirus disease 2019 (COVID-19) cases underestimate true severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections. Data on all infections, including asymptomatic infections, are needed. To minimize biases in est
Autor:
Sarah Schillie, Heather Bradley, Eric W. Hall, Patrick S. Sullivan, Jeb Jones, Ben Lopman, Adam S. Vaughan, Eli S. Rosenberg
Publikováno v:
Hepatology (Baltimore, Md.)
BACKGROUND AND AIMS Since 2013, the national hepatitis C virus (HCV) death rate has steadily declined, but this decline has not been quantified or described on a local level. APPROACH AND RESULTS We estimated county‐level HCV death rates and assess
Autor:
Lauren E. McCullough, Maret L. Maliniak, Avnika B. Amin, Julia M. Baker, Davit Baliashvili, Julie Barberio, Chloe M. Barrera, Carolyn A. Brown, Lindsay J. Collin, Alexa A. Freedman, David C. Gibbs, Maryam B. Haddad, Eric W. Hall, Sarah Hamid, Kristin R. V. Harrington, Aaron M. Holleman, John A. Kaufman, Mohammed A. Khan, Katie Labgold, Veronica C. Lee, Amyn A. Malik, Laura M. Mann, Kristin J. Marks, Kristin N. Nelson, Zerleen S. Quader, Katherine Ross-Driscoll, Supriya Sarkar, Monica P. Shah, Iris Y. Shao, Jonathan P. Smith, Kaitlyn K. Stanhope, Marisol Valenzuela-Lara, Miriam E. Van Dyke, Kartavya J. Vyas, Timothy L. Lash
Publikováno v:
Science Advances. 8
In 1995, journalist Gary Taubes published an article in Science titled “Epidemiology faces its limits,” which questioned the utility of nonrandomized epidemiologic research and has since been cited more than 1000 times. He highlighted numerous ex
Publikováno v:
The Journal of Pediatrics. :113409
Assessing the cost-utility of preferentially administering Heplisav-B vaccine to certain populations
Autor:
Eric W. Hall, Sarah Schillie, Noele P. Nelson, Eli S. Rosenberg, Aaron M. Harris, Elizabeth M. Rosenthal
Publikováno v:
Vaccine. 38:8206-8215
Vaccination is the primary strategy to prevent hepatitis B virus (HBV) infection in the United States. Prior to 2017, most standard hepatitis B vaccine schedules required 3 doses over 6 months. Heplisav-B, approved in 2017, is administered in 2 doses